BFRIW Biofrontera Inc. - Warrants
$0.03
Price · Aug 19, 2026
Fundamentals as of Aug 13, 2026
BFRIW Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$0.03
Market Cap
—
P/E (TTM)
—
EPS (TTM)
$-1.04
Revenue (TTM)
$42M
Div Yield
—
ROE
—
Debt/Equity
—
52W Range
$0 – $0
BFRIW Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Configure
10-Year Performance Revenue, net income, margins and EPS trends
Revenue & Net Income
$42M
2020-12-31
→
2025-12-31
EPS
$-1.04
2022-12-31
→
2025-12-31
Free Cash Flow
—
2023-12-31
→
2024-12-31
Margins
—
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Metric
5Y trend
BFRIW
Peer Median
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Metric
5Y trend
BFRIW
Peer Median
Financial Health Debt, liquidity, solvency — balance sheet strength
Metric
5Y trend
BFRIW
Peer Median
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Metric
5Y trend
BFRIW
Peer Median
Revenue YoY
11.8%
—
Revenue CAGR 3Y
13.3%
—
Revenue CAGR 5Y
17.2%
—
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Metric
5Y trend
BFRIW
Peer Median
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement 16
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $42M | $37M | $34M | $29M | $24M | $19M | |
| R&D Expense | $4M | $2M | $77.0K | · | · | · | |
| SG&A Expense | $38M | $34M | $18M | $35M | $37M | $18M | |
| Operating Expenses | $53M | $55M | $57M | $47M | $49M | $28M | |
| Operating Income | $-11M | $-17M | $-23M | $-19M | $-25M | $-10M | |
| Interest Expense | · | · | $220.0K | $12.0K | $344.0K | $3M | |
| Interest Income | · | $71.0K | $132.0K | $165.0K | $16.0K | $28.0K | |
| Other Non-op | $388.0K | $158.0K | $-75.0K | $33.0K | $689.0K | $2M | |
| Pretax Income | $-11M | $-18M | $-20M | $-608.0K | $-38M | $-11M | |
| Income Tax | $25.0K | $22.0K | $14.0K | $32.0K | $56.0K | $64.0K | |
| Net Income | $-11M | $-18M | $-20M | $-640.0K | $-38M | $-11M | |
| EPS (Basic) | $-1.04 | $-3.22 | $-13.02 | $-0.61 | $-4.28 | · | |
| EPS (Diluted) | $-1.04 | $-3.22 | $-13.02 | $-0.61 | · | · | |
| Shares (Basic) | 10,171,921 | 5,516,334 | 1,546,297 | 1,056,988 | 8,808,233 | · | |
| Shares (Diluted) | 10,171,921 | 5,516,334 | 1,546,297 | 1,056,988 | · | · | |
| EBITDA | · | $-17M | $-23M | $-19M | $-25M | · |
Balance Sheet 24
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $6M | $6M | $1M | $17M | $25M | $8M | |
| Receivables | $7M | · | · | · | · | · | |
| Inventory | $1M | $7M | $11M | $7M | $4M | $7M | |
| Prepaid Expense | $2M | $527.0K | $425.0K | $810.0K | $5M | $1M | |
| Current Assets | $18M | $21M | $23M | $43M | $46M | $20M | |
| PP&E (Net) | $2M | $80.0K | $134.0K | $204.0K | $267.0K | $370.0K | |
| PP&E (Gross) | $2M | $693.0K | $691.0K | $711.0K | $673.0K | $661.0K | |
| Accum. Depreciation | $267.0K | $613.0K | $557.0K | $507.0K | $406.0K | $291.0K | |
| Intangibles | $3M | $35.0K | $3M | $3M | $3M | $4M | |
| Total Assets | $29M | $22M | $28M | $51M | $53M | $24M | |
| Accounts Payable | · | · | · | $1M | $658.0K | $176.0K | |
| Accrued Liabilities | · | $4M | $4M | $11M | $10M | $3M | |
| Short-term Debt | · | · | $4M | · | · | · | |
| Current Liabilities | $12M | $12M | $18M | $21M | $14M | $4M | |
| Capital Leases | $1M | $276.0K | $804.0K | $848.0K | · | · | |
| Other Non-current Liabilities | $9.0K | $23.0K | $37.0K | $21.0K | $6M | $62.0K | |
| Total Liabilities | $18M | $18M | $23M | $27M | $42M | $18M | |
| Total Debt | · | · | $4M | · | · | · | |
| Common Stock | $12.0K | $9.0K | $2.0K | $1.0K | $17.0K | $8.0K | |
| Paid-in Capital | $138M | $122M | $104M | $103M | $90M | · | |
| Retained Earnings | $-128M | $-117M | $-100M | $-80M | $-79M | $-41M | |
| Stockholders' Equity | $10M | $4M | $5M | $24M | $11M | $6M | |
| Liabilities + Equity | $29M | $22M | $28M | $51M | $53M | $24M | |
| Shares Outstanding | 11,648,323 | 8,873,932 | 1,517,628 | 1,334,950 | 17,104,749 | 8,000,000 |
Cash Flow 14
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| D&A | $138.0K | $421.0K | $600.0K | · | · | · | |
| Stock-based Comp | $951.0K | $1M | $1M | $2M | $129.0K | · | |
| Amort. of Intangibles | · | $329.0K | $418.0K | $418.0K | $418.0K | $418.0K | |
| Restructuring | · | · | · | · | $752.0K | $1M | |
| Operating Cash Flow | $-13M | $-10M | $-25M | $-16M | $-27M | $-12M | |
| CapEx | $2.0K | $10.0K | $5.0K | $38.0K | · | · | |
| Investing Cash Flow | $3M | $-3.0K | $619.0K | $-5M | $-11.0K | · | |
| Stock Issued | · | · | $5M | · | $15M | · | |
| Net Stock Activity | · | · | · | · | $15M | · | |
| Financing Cash Flow | $11M | $15M | $8M | $14M | $43M | $13M | |
| Net Change in Cash | $487.0K | $5M | $-16M | $-7M | $16M | $825.0K | |
| Taxes Paid | $25.0K | $24.0K | $15.0K | $32.0K | $56.0K | $64.0K | |
| Free Cash Flow | · | $-10M | $-25M | · | · | · | |
| Levered FCF | · | · | $-25M | · | · | · |
Profitability 7
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Operating Margin | · | -46.1% | -66.6% | -64.8% | -104.6% | · | |
| Net Margin | · | -47.6% | -59.1% | -2.2% | -156.5% | · | |
| Pretax Margin | · | -47.5% | -59.0% | -2.1% | -156.2% | · | |
| EBITDA Margin | · | -46.1% | -66.6% | -64.8% | -104.6% | · | |
| ROA | · | -71.0% | -51.1% | -1.2% | -97.5% | · | |
| ROE | · | -356.5% | -690.5% | -2.8% | 1248.4% | · | |
| ROIC | · | -388.7% | -260.9% | -81.9% | -222.6% | · |
Liquidity & Solvency 4
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | · | 1.7 | 1.3 | 2.1 | 3.4 | · | |
| Quick Ratio | · | 0.5 | 0.1 | 0.8 | 1.8 | · | |
| Debt / Equity | · | · | 0.8 | · | · | · | |
| Interest Coverage | · | · | -103.1 | -95.3 | -73.3 | · |
Efficiency 1
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | · | 1.5 | 0.9 | 0.6 | 0.6 | · |
Growth Rates 3
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue YoY | 11.8% | 9.5% | 18.8% | 19.0% | 27.9% | · | |
| Revenue CAGR 3Y | 13.3% | 15.7% | 21.8% | · | · | · | |
| Revenue CAGR 5Y | 17.2% | · | · | · | · | · |
Valuation (TTM) 2
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $42M | $37M | $34M | $29M | $24M | · | |
| Net Income TTM | $-11M | $-18M | $-20M | $-640.0K | $-38M | · |
Income Statement 16
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $12M | $10M | $17M | $7M | $9M | $9M | $13M | $9M | $8M | $8M | $11M | $9M | $6M | $9M | $10M | $4M | |
| R&D Expense | $448.0K | $900.0K | $788.0K | $854.0K | $870.0K | $1M | $782.0K | $669.0K | $621.0K | $17.0K | $33.0K | $33.0K | $11.0K | · | · | · | |
| SG&A Expense | $10M | $11M | $9M | $10M | $11M | $9M | $8M | $8M | $8M | $9M | $-11M | $9M | $11M | $10M | $10M | $8M | |
| Operating Expenses | $13M | $14M | $13M | $13M | $14M | $13M | $14M | $14M | $13M | $13M | $14M | $14M | $15M | $14M | $16M | $8M | |
| Operating Income | $-524.0K | $-4M | $5M | $-6M | $-5M | $-5M | $-2M | $-5M | $-5M | $-5M | $-4M | $-5M | $-9M | $-5M | $-6M | $-4M | |
| Interest Expense | · | · | · | · | · | · | · | · | $620.0K | $1M | · | $142.0K | $32.0K | $2.0K | $-119.0K | $89.0K | |
| Interest Income | · | · | · | · | · | $14.0K | · | $17.0K | · | $14.0K | $21.0K | $13.0K | $40.0K | · | $55.0K | $1.0K | |
| Other Non-op | $26.0K | $-88.0K | $721.0K | $30.0K | $-264.0K | $-99.0K | $4.0K | $-32.0K | $6.0K | $180.0K | $-139.0K | $35.0K | $62.0K | $-33.0K | $3.0K | $-22.0K | |
| Pretax Income | $-581.0K | $-5M | $6M | $-7M | $-5M | $-4M | $-1M | $-6M | $-237.0K | $-10M | $4M | $-6M | $-10M | $-7M | $-3M | $-3M | |
| Income Tax | $23.0K | · | $-1.0K | $6.0K | $21.0K | $-1.0K | $-2.0K | $3.0K | $20.0K | $1.0K | $-6.0K | $1.0K | $14.0K | $5.0K | $1.0K | $1.0K | |
| Net Income | $-604.0K | $-5M | $6M | $-7M | $-5M | $-4M | $-1M | $-6M | $-257.0K | $-10M | $4M | $-6M | $-10M | $-7M | $-3M | $-3M | |
| EPS (Basic) | $-0.05 | $-0.41 | $0.62 | $-0.62 | $-0.57 | $-0.47 | $0.69 | $-0.98 | $-0.05 | $-2.88 | $4.45 | $-4.64 | $-7.23 | $-5.60 | $2.22 | $-2.26 | |
| EPS (Diluted) | $-0.05 | $-0.41 | $0.62 | $-0.62 | $-0.57 | $-0.47 | $0.69 | $-0.98 | $-0.05 | $-2.88 | $4.45 | $-4.64 | $-7.23 | $-5.60 | $2.23 | $-2.26 | |
| Shares (Basic) | 12,923,710 | 11,683,323 | -18,830,307 | 10,776,739 | 9,351,557 | 8,873,932 | -8,972,605 | 5,773,993 | 5,091,353 | 3,623,593 | -2,516,234 | 1,366,842 | 1,360,739 | 1,334,950 | -18,125,227 | 1,136,291 | |
| Shares (Diluted) | 12,923,710 | 11,683,323 | -18,830,307 | 10,776,739 | 9,351,557 | 8,873,932 | -8,972,605 | 5,773,993 | 5,091,353 | 3,623,593 | -2,516,234 | 1,366,842 | 1,360,739 | 1,334,950 | -18,153,696 | 1,136,291 | |
| EBITDA | $-524.0K | $-4M | · | $-6M | $-5M | $-5M | · | $-5M | $-5M | $-5M | · | $-5M | $-9M | $-5M | · | $-4M |
Balance Sheet 24
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $5M | $6M | $6M | $3M | $7M | $2M | $6M | $3M | $4M | $4M | $1M | $3M | $4M | $14M | $17M | $28M | |
| Receivables | $6M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Inventory | $1M | $1M | $1M | $4M | $4M | $7M | $7M | $7M | $4M | $7M | $11M | $16M | $15M | $7M | $7M | $12M | |
| Prepaid Expense | $892.0K | $1M | $2M | $629.0K | $331.0K | $682.0K | $527.0K | $350.0K | $473.0K | $560.0K | $425.0K | $274.0K | $929.0K | $2M | $810.0K | $4M | |
| Current Assets | $12M | $13M | $18M | $14M | $19M | $15M | $21M | $17M | $17M | $20M | $23M | $30M | $32M | $37M | $43M | $48M | |
| PP&E (Net) | $2M | $2M | $2M | $20.0K | $37.0K | $59.0K | $80.0K | $82.0K | $101.0K | $120.0K | $134.0K | $154.0K | $175.0K | $197.0K | $204.0K | $224.0K | |
| PP&E (Gross) | $2M | $2M | $2M | · | · | · | $693.0K | · | · | · | · | · | · | $725.0K | $711.0K | $709.0K | |
| Accum. Depreciation | $272.0K | $272.0K | $267.0K | · | · | · | $613.0K | · | · | · | · | · | · | $528.0K | $507.0K | $485.0K | |
| Intangibles | $3M | $3M | $3M | $22.0K | $26.0K | $31.0K | $35.0K | $39.0K | $2M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Total Assets | $24M | $25M | $29M | $15M | $20M | $17M | $22M | $19M | $22M | $25M | $28M | $34M | $37M | $42M | $51M | $55M | |
| Accounts Payable | · | · | · | · | · | · | · | · | · | · | · | · | $1M | $887.0K | · | $253.0K | |
| Accrued Liabilities | · | $500.0K | · | · | · | · | · | $5M | $4M | $4M | $4M | $11M | $11M | $11M | $11M | $9M | |
| Short-term Debt | · | · | · | · | · | · | · | · | $296.0K | $2M | $4M | · | · | · | · | · | |
| Current Liabilities | $11M | $11M | $12M | $13M | $20M | $11M | $12M | $11M | $9M | $14M | $18M | $29M | $25M | $20M | $21M | $17M | |
| Capital Leases | $2M | $2M | $1M | $136.0K | $223.0K | $220.0K | $276.0K | $324.0K | $443.0K | $621.0K | $804.0K | $562.0K | $600.0K | $725.0K | $848.0K | · | |
| Other Non-current Liabilities | $9.0K | $6.0K | $9.0K | $12.0K | $14.0K | $21.0K | $23.0K | $29.0K | $31.0K | $33.0K | $37.0K | $38.0K | $40.0K | $24.0K | $21.0K | $6M | |
| Total Liabilities | $18M | $19M | $18M | $18M | $25M | $16M | $18M | $13M | $11M | $26M | $23M | $33M | $30M | $25M | $27M | $32M | |
| Total Debt | · | · | · | · | · | · | · | · | $296.0K | $2M | · | · | · | · | · | · | |
| Common Stock | $14.0K | $12.0K | $12.0K | $12.0K | $9.0K | $9.0K | $9.0K | $7.0K | $5.0K | $5.0K | $2.0K | $1.0K | $27.0K | $27.0K | $1.0K | $23.0K | |
| Paid-in Capital | $139M | $139M | $138M | $131M | $122M | $122M | $122M | $122M | $121M | $105M | $104M | $104M | $104M | $104M | $103M | $99M | |
| Retained Earnings | $-133M | $-133M | $-128M | $-134M | $-127M | $-122M | $-117M | $-116M | $-110M | $-110M | $-100M | $-103M | $-97M | $-87M | $-80M | $-77M | |
| Stockholders' Equity | $6M | $6M | $10M | $-3M | $-5M | $469.0K | $4M | $6M | $11M | $-5M | $5M | $1M | $7M | $17M | $24M | $23M | |
| Liabilities + Equity | $24M | $25M | $29M | $15M | $20M | $17M | $22M | $19M | $22M | $25M | $28M | $34M | $37M | $42M | $51M | $55M | |
| Shares Outstanding | 14,206,126 | 11,873,323 | 11,648,323 | 11,648,323 | 10,138,567 | 8,873,932 | 8,873,932 | 6,529,792 | 5,094,184 | 5,089,413 | 1,517,628 | 1,367,628 | 1,367,628 | 26,699,002 | 1,334,950 | 23,550,960 |
Cash Flow 12
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $65.0K | $55.0K | · | · | $26.0K | $29.0K | · | · | · | · | · | · | · | · | · | · | |
| Stock-based Comp | $263.0K | $342.0K | $289.0K | $236.0K | $187.0K | $239.0K | $299.0K | $288.0K | $204.0K | $228.0K | $228.0K | $207.0K | $259.0K | $351.0K | $383.0K | $401.0K | |
| Amort. of Intangibles | · | · | · | $4.0K | $4.0K | $4.0K | · | $109.0K | $100.0K | $107.0K | $113.0K | $100.0K | $100.0K | $105.0K | $113.0K | $100.0K | |
| Other Non-cash | · | $4M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-2M | $-70.0K | $-2M | $-4M | $-3M | $-4M | $-1M | $-1M | $-5M | $-3M | $-9M | $-2M | $-10M | $-4M | $-8M | $-6M | |
| CapEx | $0 | $5.0K | $-1.0K | $-1.0K | $1.0K | $3.0K | $1.0K | $0 | $-48.0K | $57.0K | $-9.0K | $0 | $0 | $14.0K | $1.0K | $1.0K | |
| Investing Cash Flow | $0 | $-5.0K | $3M | $1.0K | $-1.0K | $-3.0K | $-1.0K | $0 | · | · | $73.0K | $382.0K | $178.0K | $-14.0K | $-2M | $-3M | |
| Financing Cash Flow | · | · | $2M | $0 | · | · | $4M | $-298.0K | $5M | $6M | $7M | $591.0K | · | · | $0 | $5M | |
| Net Change in Cash | $-2M | $-75.0K | $3M | $-4M | $5M | $-4M | $3M | $-2M | $562.0K | $2M | $-2M | $-1M | $-9M | $-4M | $-10M | $-4M | |
| Taxes Paid | · | · | $0 | $4.0K | · | · | $-1.0K | $4.0K | · | · | $-6.0K | · | · | $22.0K | $2.0K | $0 | |
| Free Cash Flow | · | $-75.0K | · | · | · | $-4M | · | · | · | $-3M | · | · | · | · | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $-5M | · | · | · | · | · | · |
Profitability 7
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -4.4% | -42.8% | · | -89.8% | -56.2% | -52.9% | · | -55.0% | -64.7% | -69.1% | · | -51.9% | -148.8% | -62.9% | · | -84.2% | |
| Net Margin | -5.0% | -47.1% | · | -95.2% | -59.0% | -48.9% | · | -62.9% | -3.3% | -131.9% | · | -71.3% | -168.2% | -85.6% | · | -59.4% | |
| Pretax Margin | -4.8% | -47.1% | · | -95.1% | -58.7% | -48.9% | · | -62.9% | -3.0% | -131.9% | · | -71.3% | -168.0% | -85.6% | · | -59.4% | |
| EBITDA Margin | -4.4% | -42.3% | · | -89.8% | -56.2% | -52.9% | · | -55.0% | -64.7% | -69.1% | · | -51.9% | -148.8% | -62.9% | · | -84.2% | |
| ROA | -2.7% | -23.0% | · | -39.2% | -25.5% | -20.4% | · | -21.6% | -0.88% | -31.4% | · | -14.2% | -21.7% | -16.4% | · | -7.3% | |
| ROE | -93.8% | -145.3% | · | -450.9% | -170.6% | 169.9% | · | -172.6% | -2.8% | -184.2% | · | -53.7% | -80.6% | -43.8% | · | -98.4% | |
| ROIC | -9.2% | · | · | 243.5% | 109.2% | -969.3% | · | -89.7% | -49.1% | 178.6% | · | -445.2% | -121.4% | -32.8% | · | -16.1% |
Liquidity & Solvency 4
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.2 | 1.2 | · | 1.1 | 1.0 | 1.4 | · | 1.5 | 1.9 | 1.4 | · | 1.0 | 1.3 | 1.8 | · | 2.8 | |
| Quick Ratio | 1.0 | 0.6 | · | 0.3 | 0.4 | 0.2 | · | 0.3 | 0.5 | 0.3 | · | 0.1 | 0.2 | 0.7 | · | 1.6 | |
| Debt / Equity | · | · | · | · | · | · | · | · | 0.0 | -0.4 | · | · | · | · | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | -8.2 | -3.8 | · | -32.5 | -110.1 | -2746.0 | · | -40.9 |
Efficiency 2
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | 0.5 | · | 0.4 | 0.4 | 0.4 | · | 0.3 | 0.3 | 0.2 | · | 0.2 | 0.1 | 0.2 | · | 0.1 | |
| Receivables Turnover | 4.3 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
Valuation (TTM) 10
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $38M | $35M | · | $34M | $34M | $33M | · | $34M | $30M | $31M | · | $28M | $23M | $27M | · | $23M | |
| Net Income TTM | $-17M | $-21M | · | $-22M | $-15M | $-21M | · | $-23M | $-27M | $-34M | · | $-26M | $-21M | $-5M | · | $-14M | |
| Market Cap | $895.0K | $748.0K | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P/E | -0.0 | -0.0 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P/S | 0.0 | 0.0 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P/B | 0.2 | 0.1 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P / Tangible Book | 0.3 | 0.2 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P / Cash Flow | · | -10.7 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P / FCF | · | -10.0 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -2619.1% | -3285.7% | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
Income Statement
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Revenue | $42M | $37M | $34M | $29M | $24M |
| Operating Margin % | — | -46.1% | -66.6% | -64.8% | -104.6% |
| Net Income | $-11M | $-18M | $-20M | $-640.0K | $-38M |
| Diluted EPS | $-1.04 | $-3.22 | $-13.02 | $-0.61 | — |
Balance Sheet
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Debt / Equity | — | — | 0.8 | — | — |
| Current Ratio | — | 1.7 | 1.3 | 2.1 | 3.4 |
| Quick Ratio | — | 0.5 | 0.1 | 0.8 | 1.8 |
Cash Flow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Free Cash Flow | — | $-10M | $-25M | — | — |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
📊
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Institutional owners (13F) 6 filers · $5K total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 0 (0 vs prior Q) | 1 (+1 vs prior Q) | 0 (-1 vs prior Q) | 1 (0 vs prior Q) | -46K |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| BARD ASSOCIATES INC | $4,167 | 154,900 | 76.44% | Shares |
| CLEAR STREET LLC | $972 | 9,244 | 17.83% | Shares |
| Clear Street Group Inc. | $243 | 9,044 | 4.46% | Shares |
| OSAIC HOLDINGS, INC. | $33 | 1,100 | 0.61% | Shares |
| US BANCORP \DE\ | $27 | 1,000 | 0.50% | Shares |
| UBS Group AG | $9 | 342 | 0.17% | Shares |
Company insiders 2 insiders · 2 officers · 1 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Hermann Luebbert | CEO & Chairman | July 28, 2026 M | 352,711 | 0 | 0 | $0 |
| Eugene Frederick Leffler | Chief Financial Officer | July 28, 2026 M | 206,250 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
Activists & 5%+ owners 1 position
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Biofrontera AG, Deutsche Balaton Aktiengesellschaft, VV Beteiligungen Aktiengesellschaft, Delphi Unternehmensberatung Aktiengesellschaft, Wilhelm Konrad Thomas Zours, Alexander Link, Hansjoerg Plaggemars, Maria del Pilar de la Huerta Martinez ×3 filings | Sept. 19, 2025 | 19.99% | Amendment | Passive investment | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.